Taiwan · Delayed Price · Currency is TWD Lumosa Therapeutics Statistics
Total Valuation
TPEX:6535 has a market cap or net worth of TWD 13.16 billion. The enterprise value is 12.54 billion.
| Market Cap | 13.16B |
| Enterprise Value | 12.54B |
Important Dates
The next estimated earnings date is Tuesday, November 10, 2026.
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6535 has 167.49 million shares outstanding. The number of shares has increased by 0.40% in one year.
| Current Share Class | 167.49M |
| Shares Outstanding | 167.49M |
| Shares Change (YoY) | +0.40% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.34% |
| Owned by Institutions (%) | 7.95% |
| Float | 89.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 383.05 |
| PB Ratio | 10.57 |
| P/TBV Ratio | 10.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.47, with a Debt / Equity ratio of 0.00.
| Current Ratio | 6.47 |
| Quick Ratio | 5.25 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.01 |
| Interest Coverage | -2,281.26 |
Financial Efficiency
Return on equity (ROE) is -26.11% and return on invested capital (ROIC) is -13.13%.
| Return on Equity (ROE) | -26.11% |
| Return on Assets (ROA) | -12.15% |
| Return on Invested Capital (ROIC) | -13.13% |
| Return on Capital Employed (ROCE) | -24.36% |
| Weighted Average Cost of Capital (WACC) | 4.87% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 36 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0.16 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.27% in the last 52 weeks. The beta is 0.11, so TPEX:6535's price volatility has been lower than the market average.
| Beta (5Y) | 0.11 |
| 52-Week Price Change | -59.27% |
| 50-Day Moving Average | 91.69 |
| 200-Day Moving Average | 143.44 |
| Relative Strength Index (RSI) | 33.99 |
| Average Volume (20 Days) | 239,804 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6535 had revenue of TWD 34.37 million and -370.06 million in losses. Loss per share was -2.23.
| Revenue | 34.37M |
| Gross Profit | 18.28M |
| Operating Income | -303.41M |
| Pretax Income | -375.26M |
| Net Income | -370.06M |
| EBITDA | -299.21M |
| EBIT | -303.41M |
| Loss Per Share | -2.23 |
Balance Sheet
The company has 633.00 million in cash and 3.48 million in debt, with a net cash position of 629.52 million or 3.76 per share.
| Cash & Cash Equivalents | 633.00M |
| Total Debt | 3.48M |
| Net Cash | 629.52M |
| Net Cash Per Share | 3.76 |
| Equity (Book Value) | 1.25B |
| Book Value Per Share | 7.39 |
| Working Capital | 675.93M |
Cash Flow
| Operating Cash Flow | -261.39M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 4.19M |
| Net Borrowing | -6.85M |
| Free Cash Flow | -261.39M |
| FCF Per Share | -1.56 |
Margins
| Gross Margin | 53.18% |
| Operating Margin | -882.84% |
| Pretax Margin | -1,091.93% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6535 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.40% |
| Shareholder Yield | -0.40% |
| Earnings Yield | -2.81% |
| FCF Yield | -1.99% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:6535 has an Altman Z-Score of 143.53 and a Piotroski F-Score of 3.
| Altman Z-Score | 143.53 |
| Piotroski F-Score | 3 |